Daily Sepsis Research Analysis
Analyzed 58 papers and selected 3 impactful papers.
Summary
Analyzed 58 papers and selected 3 impactful articles.
Selected Articles
1. Pathogen characteristics are key determinants of distinct host response phenotypes of sepsis.
Across 8,280 ICU sepsis cases, pathogen identity (notably Enterobacterales), burden, virulence, and infection site independently mapped to hyperinflammatory vs hypoinflammatory phenotypes. Animal models reproduced these relationships, lactate clearance prognostics varied by phenotype, and endotoxin removal harmed hypoinflammatory patients in secondary analysis.
Impact: This work reframes sepsis heterogeneity by integrating pathogen features with host phenotypes, offering a path to precision stratification and tailored interventions.
Clinical Implications: Incorporating pathogen identity and burden into sepsis phenotyping may refine prognostication (e.g., lactate clearance interpretation) and identify subgroups unlikely to benefit—or potentially be harmed—by endotoxin-targeted therapies.
Key Findings
- Gram-negative, especially Enterobacterales infections, were strongly associated with the hyperinflammatory phenotype independent of severity.
- Higher pathogen burden, virulence, and initial anatomic infection site independently correlated with hyperinflammatory classification.
- Murine and swine models demonstrated that pathogen identity and burden causally reproduced hyperinflammatory features.
- Prognostic value of lactate clearance varied substantially by phenotype.
- Secondary analysis of polymyxin B hemoadsorption showed worse survival in hypoinflammatory patients.
Methodological Strengths
- Large multicenter cohort (n=8,280) with rigorous phenotype assignment
- Cross-validation via controlled murine and swine models plus secondary RCT analysis
Limitations
- Retrospective observational design with potential residual confounding
- Phenotype-pathogen associations may be influenced by diagnostic practices and culture yield variability
- Secondary analyses were not randomized by phenotype, limiting causal inference for treatment effects
Future Directions: Prospective, pathogen-informed stratified trials and clinical decision tools integrating host and pathogen features to guide targeted therapies (e.g., endotoxin removal) are warranted.
BACKGROUNDSepsis encompasses considerable biological and clinical heterogeneity. Previously, 2 phenotypes ("hyperinflammatory" and "hypoinflammatory") have been consistently identified within sepsis via latent class analysis. These phenotypes differ in their biological features, clinical outcomes, and therapeutic responses to interventions. Prior studies of sepsis heterogeneity have focused primarily on the host response. Here, we investigate the potential influence of the causative pathogen on sepsis heterogeneity and pathobiology.METHODSWe performed a retrospective observational analysis of 8,280 critically ill patients with sepsis to identify associations between pathogen characteristics and the hyperinflammatory and hypoinflammatory patient phenotypes. We also performed controlled murine and swine modeling of sepsis and lung injury and a secondary analysis of 449 patients enrolled in the EUPHRATES randomized controlled trial.RESULTSPathogen characteristics (pathogen identity, burden, virulence, and anatomic site of infection) were strongly and independently associated with the previously reported phenotypes. In a cohort of critically ill patients with sepsis, infection with gram-negative pathogens, primarily Enterobacterales spp. (e.g., Escherichia coli, Klebsiella pneumoniae), was strongly associated with the hyperinflammatory phenotype. The hyperinflammatory phenotype was also independently associated with increased pathogen burden, virulence, and initial anatomic site of infection. In controlled murine and swine modeling, both the identity and burden of the pathogen provoked key biological features of the hyperinflammatory phenotype. Among patients with sepsis, the prognostic value of lactate clearance varied substantially by phenotype. In a secondary analysis of a randomized trial of polymyxin B hemoadsorption (which removes circulating endotoxin), hypoinflammatory patients experienced worse survival.CONCLUSIONSOur results demonstrate the central importance of pathogen features in the clinical and biological heterogeneity of sepsis. Future studies of sepsis pathobiology and heterogeneity should expand their scope beyond the host response, as understanding pathogen-host interactions will be crucial in the development of precision therapeutic strategies to improve patient outcomes.TRIAL REGISTRATIONEUPHRATES trial NCT01046669.FUNDING5P30AG024824, IK2CX002766, R01HL144599, K24HL159247, R01HL158626, R01HL173531, R35GM142992, R35GM145330, R35GM136312, K23HL166880, R35HL140026.
2. Efficacy and Safety of Procalcitonin-guided Antibiotic Therapy versus Standard of Care for Sepsis: A Systematic Review and Meta-analysis.
Across 16 RCTs (n=6,885), PCT-guided therapy shortened antibiotic duration and mechanical ventilation and modestly increased antibiotic-free days, without reducing mortality. Reinfection risk was slightly higher, and heterogeneity for antibiotic duration was substantial.
Impact: Provides high-level synthesis confirming stewardship benefits of PCT-guided strategies while cautioning about reinfection and protocol heterogeneity.
Clinical Implications: Clinicians can consider PCT algorithms to safely reduce antibiotic exposure in sepsis, but should adopt standardized thresholds and stopping rules and monitor for reinfection.
Key Findings
- PCT guidance reduced antibiotic duration (SMD -0.81; 95% CI -1.17 to -0.45) with high heterogeneity (I2 97%).
- Mechanical ventilation duration decreased under PCT guidance (SMD -0.47; I2 0%).
- Antibiotic-free days modestly increased (SMD 0.14; I2 0%).
- No differences in ICU, hospital, 30-day, or 90-day mortality; or length of stay.
- Reinfection risk was slightly higher with PCT guidance (RR 1.12; 95% CI 1.00–1.26).
Methodological Strengths
- Meta-analysis of 16 randomized controlled trials with 6,885 participants
- Appropriate random-effects modeling and separate handling of dichotomous and continuous outcomes
Limitations
- Substantial heterogeneity in antibiotic duration effect (I2=97%)
- Variation in PCT thresholds and stopping rules across trials limits generalizability
- No mortality benefit observed; slight increase in reinfections
Future Directions: Harmonized, protocolized PCT algorithms and patient-level meta-analyses to define optimal thresholds and subgroups that maximize benefit while minimizing reinfection.
OBJECTIVES: This systematic review and meta-analysis assesses the efficacy and safety of procalcitonin (PCT) guided therapy compared to standard of care (SOC) in septic patients. METHODS: A comprehensive literature search was performed using the Cochrane Library, ClinicalTrials.gov, Embase, and MEDLINE, covering studies from their inception to April 2025. RevMan was used to perform a random-effects meta-analysis, and forest plots were used to visualize the pooled estimates. The Mantel-Haenszel method was applied to analyze dichotomous outcomes. The inverse variance method was applied to analyze continuous outcomes. RESULTS: Sixteen randomized controlled trials (RCTs), with a total of 6,885 patients, were included. PCT-guided therapy was associated with significantly improved antibiotic treatment duration (standardized mean difference [SMD] -0.81, 95% CI -1.17 to -0.45, I2 97%), duration of mechanical ventilation (SMD -0.47, 95%CI -0.57 to - 0.37, I2 0%) and antibiotic-free days (SMD 0.14, 95% CI 0.04-0.25, I2 0%). Both groups were comparable in terms of ICU mortality, hospital mortality, 30-day mortality, 90-day mortality, ICU stay, hospital stay, new infection and clinical recovery. PCT was associated with greater reinfection (RR 1.12, 95% CI 1.00- 1.26, I2 0%). CONCLUSION: PCT-guided therapy was associated with shorter antibiotic treatment duration, though substantial heterogeneity was observed, while mortality outcomes were comparable between groups. Standardized PCT-based protocols are needed to improve consistency and clinical applicability.
3. Timely antibiotics and fluid resuscitation are associated with increased discharge to home after sepsis.
In a 67-hospital cohort of 38,568 adults with community-onset sepsis, on-time antibiotics and 30 mL/kg fluid resuscitation were each independently associated with higher odds of discharge to home (+3.0 and +1.1 absolute percentage points, respectively). Associations were robust across sensitivity and subgroup analyses.
Impact: Shifts focus beyond mortality to functional disposition, linking sepsis bundle timeliness to patient-centered outcomes and potential cost savings.
Clinical Implications: Hospitals should prioritize reliable systems for early antibiotics and guideline-concordant fluids to improve chances of home discharge and reduce post-acute institutionalization.
Key Findings
- Timely antibiotics (≤3 h if hypotensive; else ≤5 h) occurred in 75.3% of eligible patients and were associated with a +3.0 pp increase in discharge to home.
- Timely fluid resuscitation (≥30 mL/kg) occurred in 49.5% and was associated with a +1.1 pp increase in discharge to home.
- Findings were consistent across sensitivity and subgroup analyses in a large, 67-hospital cohort.
Methodological Strengths
- Very large, multicenter real-world cohort with standardized performance measures
- Multivariable adjustment with robust sensitivity and subgroup analyses
Limitations
- Observational design with potential residual confounding and selection biases
- Antibiotic timing assessed only in patients without positive viral testing; generalizability may be limited to one statewide consortium
- Unmeasured confounders (e.g., source control timing) could influence disposition
Future Directions: Implementation trials to optimize time-to-therapy processes and evaluate impacts on functional outcomes, equity, and costs across diverse health systems.
BACKGROUND: Sepsis is a devastating condition with frequent discharge to non-home settings such as skilled nursing facilities. Bundled payment incentive programs targeting sepsis have tried to encourage lower spending by avoiding discharge to institutional post-acute care. QUESTIONS: What is the impact of timely antibiotic delivery and fluid resuscitation on discharge to home after sepsis? STUDY DESIGN AND METHODS: Observational cohort study of adults hospitalized for confirmed community-onset sepsis at 67 hospitals participating in Michigan Hospital Medicine Safety Consortium's sepsis initiative (HMS-Sepsis) during 2022-2025. Timely antibiotic delivery and fluid resuscitation were assessed via performance measures used for statewide benchmarking. Antibiotic delivery was measured in patients without positive viral testing. Target administration was ≤3 hours of emergency department arrival among patients presenting with hypotension, else ≤5 hours. Fluid resuscitation (≥30ml/kg body weight) was measured in patients with hypotension or elevated lactate. The primary outcome was discharge to home. RESULTS: Among 38,568 patients with community-onset sepsis (18,941 male [49.1%]; median age 71 years [Q1-Q3: 61-80 years], 7,942 (20.6%) died in hospital or were discharged to hospice; 9,941 (25.8%) were discharged to a post-acute care facility; and 20,685 (53.6%) were discharged to home. Among 35,025 and 27,393 eligible patients, timely antibiotic delivery and fluid resuscitation occurred in 26,357 (75.3%) and 13,561 (49.5%), respectively. In multivariable models adjusted for patient characteristics, timely antibiotic administration and fluid resuscitation were associated with a 3.0 (95% CI: 2.0-4.0) and 1.1 (95% CI 0.2-2.1) absolute percentage point increase in discharge to home, respectively. Findings were robust across sensitivity and subgroup analyses. INTERPRETATION: In this multihospital cohort, timely antibiotic delivery and fluid resuscitation were associated with increased discharge to home after sepsis. This finding suggests that timely treatment of sepsis may reduce downstream morbidity and healthcare expenditures.